Pivotal bioVenture Partners Investment Advisor LLC Long-Term Concentrated

CIK: 0001844645 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 13, 2026

Total Value ($000): $258,658 (100.0% shares, 0.0% debt)

Holdings (12)

New Positions (2)

EVMN EVOMMUNE INC 12.8%

Value ($000) $32,989 Shares 1,926,943 Est. Cost $18.78 Unrealized 0.0%

MPLT MAPLIGHT THERAPEUTICS INC 4.2%

Value ($000) $10,743 Shares 611,447 Est. Cost $16.75 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
EVMN	EVOMMUNE INC	1,926,943	$32,989	12.8%	$18.78	0.0%	COM SHS	30054Y107
MPLT	MAPLIGHT THERAPEUTICS INC	611,447	$10,743	4.2%	$16.75	0.0%	COM	56565P103

Increased Positions (1)

IMNM IMMUNOME INC 6.1%

Value ($000) $15,734 (+167.4%) Shares 732,512 (+45.8%) Est. Cost $12.33 Unrealized +42.3%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
IMNM	IMMUNOME INC	732,512 (+45.8%)	$15,734 (+167.4%)	6.1%	$12.33	+42.3%	COM	45257U108

Decreased Positions (2)

ZBIO ZENAS BIOPHARMA INC 8.3%

Value ($000) $21,495 (+24.3%) Shares 591,991 (-24.0%) Est. Cost $17.27 Unrealized +90.5%

ARQT ARCUTIS BIOTHERAPEUTICS INC 15.3%

Value ($000) $39,687 (-0.7%) Shares 1,366,624 (-35.6%) Est. Cost $11.27 Unrealized +127.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ZBIO	ZENAS BIOPHARMA INC	591,991 (-24.0%)	$21,495 (+24.3%)	8.3%	$17.27	+90.5%	COM	98937L105
ARQT	ARCUTIS BIOTHERAPEUTICS INC	1,366,624 (-35.6%)	$39,687 (-0.7%)	15.3%	$11.27	+127.2%	COM	03969K108

Unchanged Positions (7)

PCVX VAXCYTE INC 24.5%

Value ($000) $63,324 Shares 1,372,425 Est. Cost $38.62 Unrealized +15.8%

OCS OCULIS HOLDING AG 17.7%

Value ($000) $45,705 Shares 2,288,658 Est. Cost $12.64 Unrealized +58.3%

BIOA BIOAGE LABS INC 3.3%

Value ($000) $8,644 Shares 653,374 Est. Cost $19.50 Unrealized -54.5%

TRVI TREVI THERAPEUTICS INC 6.1%

Value ($000) $15,735 Shares 1,256,782 Est. Cost $6.33 Unrealized +82.5%

RXRX RECURSION PHARMACEUTICALS IN 0.9%

Value ($000) $2,436 Shares 595,518 Est. Cost $6.72 Unrealized -26.3%

— RALLYBIO CORP 0.6%

Value ($000) $1,650 Shares 2,404,644 Est. Cost $16.97 Unrealized —

BOLT BOLT BIOTHERAPEUTICS INC 0.2%

Value ($000) $517 Shares 94,573 Est. Cost $6.62 Unrealized -18.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PCVX	VAXCYTE INC	1,372,425	$63,324	24.5%	$38.62	+15.8%	COM	92243G108
OCS	OCULIS HOLDING AG	2,288,658	$45,705	17.7%	$12.64	+58.3%	ORDINARY SHARES	H5870P102
BIOA	BIOAGE LABS INC	653,374	$8,644	3.3%	$19.50	-54.5%	COM	09077V100
TRVI	TREVI THERAPEUTICS INC	1,256,782	$15,735	6.1%	$6.33	+82.5%	COM	89532M101
RXRX	RECURSION PHARMACEUTICALS IN	595,518	$2,436	0.9%	$6.72	-26.3%	CL A	75629V104
—	RALLYBIO CORP	2,404,644	$1,650	0.6%	$16.97	—	COM	75120L100
BOLT	BOLT BIOTHERAPEUTICS INC	94,573	$517	0.2%	$6.62	-18.9%	COM NEW	097702203